DuvaSawko, predominantly serves independent emergency physician groups and hospital-based emergency departments. The company currently serves clients with more than 2.3 million annual emergency room patient visits across nearly 70 locations in 10 states.
Here are four things to know about the transaction.
1. Recapitalization of DuvaSawko is the third U.S.-based transaction closed by Livingstone Partners’ healthcare practice this year. Livingstone is a global M&A and debt advisory firm.
2. “From start to finish, we relied heavily on Livingstone’s healthcare expertise and diverse network of strategic and financial buyers, said Charles Duva, co-founder and CEO of DuvaSawko. We found an ideal partner in Ancor Capital Partners who shares our culture and strategic vision of growth for DuvaSawko.”
3. Jim Moskal, partner in Livingstone’s healthcare practice, noted the continued demand for RCM solutions in healthcare. “This transaction highlights the increasingly important need for healthcare providers to have high-quality RCM solutions,” he said in a prepared statement. “The shifting reimbursement landscape will only exacerbate this trend.”
4. Terms of the transaction were not disclosed.
More articles on finance and revenue cycle management:
Physicians who receive lots of pharma cash prescribe more brand-name drugs, study finds
Presence CEO says poor collections to blame for $186M operating loss
House Republicans unveil 2017 budget: 7 things for healthcare leaders to know
